Publications by authors named "David Nanus"

Claim this Profile
M
Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance.
Matthew R Cooperberg, John R Bihn, John M Culnan, Jennifer La, Sergey D Goryachev, David M Nanus

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors.
Pier Vitale Nuzzo, Silvia Rodrigues, Caroline Fidalgo Ribeiro, Isadora Ferrari Teixeira, Giuseppe Nicolo' Fanelli, David M Nanus

Crit Rev Oncol Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma.
Yuling Chi, Shireen Chikara, Eduardo Mere Del Aguila, Tuo Zhang, Jacob B Geri, David M Nanus

Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATF4 in proximal tubules modulates kidney function and modifies the metabolome.
Yuling Chi, Eduardo Mere Del Aguila, Tuo Zhang, Charles D Warren, Helen R Hoxie, David M Nanus

J Mol Med (Berl)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancer.
Marjorie L Roskes, Alexander Martinez-Fundichely, Sandra Cohen, Metin Balaban, Chen Khuan Wong, David Nanus

medRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution.
Himanshu Nagar, Marshall A Diven, Brady Rippon, Christopher E Barbieri, Jim C Hu, David M Nanus

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer.
Jones T Nauseef, Timothy R Chu, William F Hooper, Alicia Alonso, Ali Oku, David M Nanus

NPJ Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual Presentation of Advanced Urothelial Cancer in a Young Patient.
Daniela Guevara, Nara Shin, Alexandra Boiko, Ivan Valiev, Ahmed G Elsaeed, David Nanus

Anticancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.
Katsuyuki Iida, Rong Zheng, Ruoqian Shen, David M Nanus

Int J Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.
Duy D Nguyen, William F Hooper, Weisi Liu, Timothy R Chu, Heather Geiger, David M Nanus

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomes.
Giuseppe Galletti, Ahmed Halima, Ada Gjyrezi, Jiaren Zhang, Bob Zimmerman, David M Nanus

medRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program.
Faith Morley, Hari S Iyer, Rulla M Tamimi, David M Nanus, Timothy R Rebbeck

Cancer Causes Control· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of Ac-J591.
Scott T Tagawa, Charlene Thomas, A Oliver Sartor, Michael Sun, Judith Stangl-Kremser, David M Nanus

J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.
Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George

Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis.
Majd Al Assaad, Nara Shin, Michael Sigouros, Jyothi Manohar, Zoia Antysheva, David M Nanus

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.
Jaclyn M Kubala, Kristian B Laursen, Ryan Schreiner, Ryan M Williams, Johannes C van der Mijn, David M Nanus

Cancer Biol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling of Skeletal Muscle and Adipose Tissue Depots in Men with Advanced Prostate Cancer Receiving Different Forms of Androgen Deprivation Therapy.
Tahj A Blow, Anirudh Murthy, Rahul Grover, Emily Schwitzer, David M Nanus

Eur Urol Open Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.
Judith Stangl-Kremser, Michael Sun, Benedict Ho, Joseph Thomas, Jones T Nauseef, David M Nanus

Prostate· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).
Ariel E Marciscano, Sydney Wolfe, Xi Kathy Zhou, Christopher E Barbieri, Silvia C Formenti, David M Nanus

BMC Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer.
Santosh Gupta, Susan Halabi, Qian Yang, Akash Roy, Alisa Tubbs, David M Nanus

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel genetically engineered mouse models for clear cell renal cell carcinoma.
Johannes C van der Mijn, Kristian B Laursen, Leiping Fu, Francesca Khani, Lukas E Dow, David M Nanus

Sci Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Molecular genetics and therapeutic advances in renal carcinoma.
David M Nanus, James H Finke, Saby George

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatalistic cancer beliefs and self-reported cancer screening behaviors among diverse urban residents.
Laura C Pinheiro, Orysya Soroka, Dominic T Razon, Francesse Antoine, Julia Rothman, David Nanus

J Behav Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer.
Seaho Kim, CheukMan C Au, Mohd Azrin Bin Jamalruddin, Naira Essam Abou-Ghali, Eiman Mukhtar, David M Nanus

Elife· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nearly All Cancer Survivors Return to Primary Care.
Laura C Pinheiro, Mangala Rajan, Monika M Safford, David M Nanus, Lisa M Kern

J Am Board Fam Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis